Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare® Test Kits | FDA

Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare® Test Kits | FDA: Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. (“Magellan”), expanded the Class I recall of its LeadCare® II Blood Lead Test Kits, LeadCare Plus® Blood Lead T

Comments

Popular posts from this blog

Dams, taps running dry in northern Mexico amid historic water shortages | Nasdaq

The conflict in Gaza: a view from Israel - The Lancet